Results 21 to 30 of about 1,088 (191)

Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six‐Month Results of a Placebo‐Controlled Trial

open access: yesArthritis &Rheumatology, Volume 73, Issue 5, Page 806-815, May 2021., 2021
Objective To investigate the efficacy of 16‐week treatment with etanercept (ETN) in patients with suspected nonradiographic axial spondyloarthritis (SpA). Methods Tumor necrosis factor inhibitor–naive patients with inflammatory back pain with at least 2 SpA features and high disease activity (Bath Ankylosing Spondylitis Disease Activity Index score ≥4),
Tamara Rusman   +9 more
wiley   +1 more source

Update in spondylarthropathy [PDF]

open access: yesArthritis Care & Research, 2004
Ankylosing spondylitis (AS) is the most common type of spondylarthropathy seen in clinical practice. Several reports have appeared in the past 2 years that have significantly advanced our understanding of the pathogenesis and treatment of this disease.
openaire   +2 more sources

Collagenous Colitis and Spondylarthropathy [PDF]

open access: yesCase Reports in Medicine, 2012
Collagenous colitis is a recent cause of chronic diarrhea. Cooccurrence with spondylarthropathy is rare. We describe two cases: one man and one woman of 33 and 20 years old were suffering from spondylarthropathy. They then developed collagenous colitis, 4 and 14 years after the onset of spondylarthropathy.
Kaouther Ben Abdelghani   +7 more
openaire   +3 more sources

Bamboo spine – X-ray findings of ankylosing spondylitis revisited

open access: yesSouth African Journal of Radiology, 2012
Ankylosing spondylitis is a debilitating disease that is one of the seronegative spondylarthropathies, affecting more males than females in the proportion of about 6:1 in the age group 15 - 35 years of age.
Antoinette Reinders, Matthys J van Wyk
doaj   +1 more source

Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review

open access: yesRheumatology and Therapy, 2019
Introduction Secukinumab is a fully human anti-interleukin 17A monoclonal antibody approved for the treatment of psoriatic arthritis (PsA) in the United States.
Prashanth Sunkureddi   +5 more
doaj   +1 more source

Biological therapy in treatment of uveitis. Contemporary trends

open access: yesJournal of Ophthalmology, 2017
Uveitis is a cause of blindness in about 10% of cases. According to many studies, TNF-? plays an important role in the development of uveitis. Anti-TNF-? are widely used in rheumatology and recently in ophthalmology.
A.V. Zborovskaia, A.E. Dorokhova
doaj   +1 more source

Musculoskeletal Manifestations in Inflammatory Bowel Disease

open access: yesCanadian Journal of Gastroenterology, 2001
Muscoloskeletal manifestations are the most common extraintestinal complications of inflammatory bowel disease. Wide ranges in prevalence have been reported, depending on the criteria used to define spondylarthropathy.
Giovanni Fornaciari   +5 more
doaj   +1 more source

Reactive arthritis: advances in diagnosis and treatment

open access: yesReumatismo, 2002
Reactive Arthritis (ReA) is an aseptic synovitis developing after a primary infection distant from the joint, mainly localized in the gastrointestinal (Enteroarthritis) or genitourinary tract (Uroarthritis).
C. Palazzi   +6 more
doaj   +1 more source

Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort

open access: yesUnited European Gastroenterology Journal, Volume 8, Issue 10, Page 1196-1207, December 2020., 2020
Objective The purpose of this study was to investigate the impact of obesity on disease activity and disease outcome in patients with inflammatory bowel disease. Patients and methods The impact of obesity on inflammatory bowel disease disease activity and outcome was retrospectively assessed in 3075 patients enrolled in the prospective nation‐wide ...
Thomas Greuter   +11 more
wiley   +1 more source

Do Smoking and Socioeconomic Factors Influence Imaging Outcomes in Axial Spondyloarthritis? Five‐Year Data From the DESIR Cohort

open access: yesArthritis &Rheumatology, Volume 72, Issue 11, Page 1855-1862, November 2020., 2020
Objective To investigate the relationship between smoking and imaging outcomes over 5 years in axial spondyloarthritis (SpA) and to assess whether socioeconomic factors influence these relationships. Methods Axial SpA patients from the Devenir des Spondylarthropathies Indifferérenciées Récentes cohort were included.
Elena Nikiphorou   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy